Tema Etfs LLC Purchases New Position in Cognex Corporation $CGNX

Tema Etfs LLC acquired a new stake in shares of Cognex Corporation (NASDAQ:CGNX) during the 2nd quarter, HoldingsChannel.com reports. The fund acquired 243,408 shares of the scientific and technical instruments company’s stock, valued at approximately $7,721,000. Cognex comprises approximately 2.1% of Tema Etfs LLC’s investment portfolio, making the stock its 4th largest holding.

Other large investors also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. increased its stake in shares of Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 736 shares during the last quarter. Penserra Capital Management LLC bought a new stake in Cognex in the second quarter worth $29,000. TD Waterhouse Canada Inc. acquired a new position in Cognex during the second quarter worth $29,000. MassMutual Private Wealth & Trust FSB raised its holdings in Cognex by 231.9% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock valued at $34,000 after buying an additional 756 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its position in shares of Cognex by 31.5% in the second quarter. Farther Finance Advisors LLC now owns 1,277 shares of the scientific and technical instruments company’s stock worth $40,000 after buying an additional 306 shares during the last quarter. 88.12% of the stock is owned by institutional investors.

Cognex Stock Up 3.2%

Shares of CGNX stock opened at $38.90 on Friday. Cognex Corporation has a 12 month low of $22.67 and a 12 month high of $49.76. The firm has a market cap of $6.52 billion, a PE ratio of 60.78 and a beta of 1.53. The stock has a 50 day moving average of $42.09 and a 200-day moving average of $38.73.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings data on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.06. The business had revenue of $264.00 million for the quarter, compared to the consensus estimate of $261.86 million. Cognex had a net margin of 11.33% and a return on equity of 8.26%. Cognex’s quarterly revenue was up 18.0% on a year-over-year basis. During the same quarter last year, the company posted $0.20 earnings per share. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. As a group, equities analysts predict that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Thursday, November 13th were given a dividend of $0.085 per share. This is an increase from Cognex’s previous quarterly dividend of $0.08. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Thursday, November 13th. Cognex’s dividend payout ratio (DPR) is currently 53.13%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CGNX. DA Davidson set a $38.00 price objective on Cognex and gave the company a “neutral” rating in a report on Monday, November 3rd. UBS Group reiterated a “buy” rating and set a $58.00 price target on shares of Cognex in a report on Friday, October 31st. Weiss Ratings reissued a “hold (c)” rating on shares of Cognex in a research report on Monday. Truist Financial set a $45.00 price objective on shares of Cognex and gave the stock a “hold” rating in a report on Wednesday, October 8th. Finally, KeyCorp reiterated an “overweight” rating and issued a $50.00 target price on shares of Cognex in a report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Cognex currently has an average rating of “Hold” and a consensus price target of $45.53.

Insider Activity

In other Cognex news, Director Robert Willett sold 6,704 shares of the company’s stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $49.51, for a total value of $331,915.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Sheila Marie Dipalma sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $45.03, for a total value of $90,060.00. Following the completion of the sale, the executive vice president owned 6,582 shares of the company’s stock, valued at $296,387.46. This represents a 23.30% decrease in their position. The SEC filing for this sale provides additional information. 1.60% of the stock is currently owned by company insiders.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.